Miravant Medical Technologies Inc.Company Review & Valuation

MRVT
OTC Markets
Latest Price
0.00USD
Market Capitalization
11.36kUSD

About Miravant Medical Technologies Inc.

Miravant Medical Technologies Inc. operates as a pharmaceutical research and development company. The company develops PhotoPoint, a photodynamic therapy that responds to light destroying cancerous cells; and manufactures light producing and light delivery devices. Its products include PHOTREX for tShow morehe treatment of wet age-related macular degeneration or AMD; MV9411, a photoreactive drug for the treatment of plaque psoriasis; MV0633 for the treatment of atherosclerosis, atherosclerotic vulnerable plaque, and restenosis; MV2101 for the treatment of vascular access graft disease in hemodialysis patients; and MV6401 for the treatment of solid tumors. Miravant Medical Technologies Inc. was formerly known as PDT, Inc. and changed its name to Miravant Medical Technologies Inc. in September 1997. The company was founded in 1989 and is headquartered in Santa Barbara, California.Show less

Industry
HQ Location
Santa Barbara, California

Stock Price

Price data not available for Miravant Medical Technologies Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Brown & Brown
Eurocash
Atos
Northrop Grumman

back to top